LESS DISEASE TARGETS? That is the assumption in traditional Pharma strategy thinking. But reflect on this: firstly, less than 2% of the druggable human genome has been spoken for. Secondly, severe tropical diseases kill tens of millions annually. The first will open due to genetics and already is (ie: genetically tailored cancer meds). The second is about economics. But as climate change drives more diseases like Dengue Fever into places like Texas, this too will change. Tropical diseases are migrating. Increasingly on our doorstep, they will attract Pharma attention. Not just Mr Gates.
http://lnkd.in/4kEv6V
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022